In addition, GSEA showed multiple enriched immune-related pathways, including the IL6 and IFN-γ signalling pathways, in ARID1A-deficient HBV-HCC, which are important for antitumour activity conducted by immune cells, especially T lymphocytes. Here, ARID1A is linked to hepatocellular carcinoma.